VLP Biotech, Inc.
Records under this name other than the patents VLP Biotech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 4 of 4 · Back to VLP Biotech, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,144,712 | Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof Term ended Term ended Nov 20, 2023 · From the USPTO record | Term ended | Term ended Nov 20, 2023 | From the USPTO record |
| US 7,320,795 | Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof Term ended Term ended Aug 19, 2023 · From the USPTO record | Term ended | Term ended Aug 19, 2023 | From the USPTO record |
| US 7,883,843 | Hepatitis virus core proteins as vaccine platforms and methods of use thereof Lapsed on the fee record Ended Feb 8, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 8, 2023 | From the USPTO record |
| US 7,811,576 | Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof Lapsed on the fee record Ended Oct 12, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 12, 2022 | From the USPTO record |